Dosing reference
Every dose that has been studied in humans
Label dosing for approved drugs, the amounts given in registered trials of investigational drugs, and a plain “none established” everywhere else. No forum numbers, no vendor charts. Every figure cites its source.
22 · FDA label15 · Trial doses71 · None established
Reconstitution guide
Lab steps with photos, syringe units and storage.
How long studies ran
Cycle-length evidence: treatment and follow-up durations.
Combinations
What is actually studied when compounds are paired.
Human dosing quick-reference chart
Click any compound for the cited dosing page, study durations and vial arithmetic.
| Compound | Research area | Status | Human amounts | Route studied | Half-life | Evidence | |
|---|---|---|---|---|---|---|---|
| Adamax | Cognitive | Not approved | None established | — | — | — | View |
| Cerebrolysin | Cognitive | Approved outside the US | Austrian label: 10 to 50 mL daily depending on indication; trials used 10 to 60 mL per administration | Intravenous infusion or injection; intramuscular up to 5 mL (Austrian label) | Not directly measurable (peptide mixture) | A | View |
| Dihexa | Cognitive | Not approved | None established | — | — | C | View |
| DSIP | Cognitive | Not approved | None established | — | — | B | View |
| Nootropic Strips | Cognitive | Not approved | None established | — | — | — | View |
| Oxytocin | Cognitive | FDA-approved | Labor: 0.5–1 mU/min by IV infusion, increased gradually; postpartum bleeding: 10–40 units in an IV infusion or 10 units IM (FDA label) | Intravenous infusion; intramuscular (postpartum) | The Pitocin label states a plasma half-life of about 1 to 6 minutes, decreased in late pregnancy and during lactation, with rapid removal from plasma accomplished largely by the kidney and liver . | A | View |
| Selank | Cognitive | Approved outside the US | None established | — | — | B | View |
| Semax | Cognitive | Approved outside the US | None established | — | — | B | View |
“Human amounts” is a summary; the dosing page for each compound carries the full cited statements. Compounds approved nowhere show “None established” by policy, whatever is circulated elsewhere. Why.
What every dosing page includes
- Quick-reference card
- Label or trial doses, cited
- How long studies ran
- Who was excluded
- Side effects reported
- Reconstitution arithmetic + syringe chart
- Supplies, storage and handling mistakes
- Regulatory status
- Comparison with related compounds
- Combinations and FAQs
Don’t see a compound?
Tell us what to research next. We add compounds when there are primary sources to cite.